Davis's Drug Guide
mavorixafor
General
Pronunciation:
mav-or-ix-a-for
Trade Name(s)
- Xolremdi
Ther. Class.
none assigned
Pharm. Class.
temporary class
CXC chemokine receptor 4 antagonistThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Mavorixafor." Davis's Drug Guide Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580215/all/mavorixafor.
Vallerand AHA, Sanoski CAC. Mavorixafor. Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580215/all/mavorixafor. Accessed October 12, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Mavorixafor. In Davis's Drug Guide Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580215/all/mavorixafor
Vallerand AHA, Sanoski CAC. Mavorixafor [Internet]. In: Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580215/all/mavorixafor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - mavorixafor
ID - 3580215
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580215/all/mavorixafor
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
